Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126814272 | 12681427 | 2 | F | 20151112 | 20160829 | 20160824 | 20160905 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-049882 | BRISTOL MYERS SQUIBB | 73.97 | YR | M | Y | 67.10000 | KG | 20160905 | CN | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126814272 | 12681427 | 1 | PS | ELIQUIS | APIXABAN | 1 | Oral | 5 MG, BID | 1840 | MG | Y | 202155 | 5 | MG | FILM-COATED TABLET | BID | |||
126814272 | 12681427 | 2 | SS | ELIQUIS | APIXABAN | 1 | Oral | 2.5 MG, BID | 1840 | MG | Y | 202155 | 2.5 | MG | FILM-COATED TABLET | BID | |||
126814272 | 12681427 | 3 | SS | PREDONINE | PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE | 1 | Oral | 5 MG, QD | 90 | MG | 0 | 5 | MG | QD | |||||
126814272 | 12681427 | 4 | SS | PREDONINE | PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE | 1 | Oral | 30 MG, QD | 90 | MG | 0 | 30 | MG | QD | |||||
126814272 | 12681427 | 5 | SS | AMIODARONE | AMIODARONE | 1 | Oral | 100 MG, QD | 0 | 100 | MG | QD | |||||||
126814272 | 12681427 | 6 | C | HERBESSER | DILTIAZEM HYDROCHLORIDE | 1 | Oral | 100 MG, BID | 0 | 100 | MG | BID | |||||||
126814272 | 12681427 | 7 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
126814272 | 12681427 | 8 | C | ALDACTONE | SPIRONOLACTONE | 1 | Oral | 25 MG, QD | 0 | 25 | MG | QD | |||||||
126814272 | 12681427 | 9 | C | THYRADIN S | LEVOTHYROXINE SODIUM | 1 | Oral | 50 ?G, QD | 0 | 50 | UG | QD | |||||||
126814272 | 12681427 | 10 | C | BLOPRESS | CANDESARTAN CILEXETIL | 1 | Oral | 8 MG, QD | 0 | 8 | MG | QD | |||||||
126814272 | 12681427 | 11 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
126814272 | 12681427 | 12 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Oral | UNK, BID | 0 | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126814272 | 12681427 | 1 | Cerebrovascular accident prophylaxis |
126814272 | 12681427 | 3 | Asthma |
126814272 | 12681427 | 5 | Atrial fibrillation |
126814272 | 12681427 | 6 | Hypertension |
126814272 | 12681427 | 7 | Cardiac failure |
126814272 | 12681427 | 8 | Cardiac failure |
126814272 | 12681427 | 9 | Hypothyroidism |
126814272 | 12681427 | 10 | Hypertension |
126814272 | 12681427 | 11 | Asthma |
126814272 | 12681427 | 12 | Asthma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126814272 | 12681427 | OT |
126814272 | 12681427 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126814272 | 12681427 | Asthma | |
126814272 | 12681427 | Haemorrhage subcutaneous | |
126814272 | 12681427 | Hypothyroidism | |
126814272 | 12681427 | Prescribed underdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126814272 | 12681427 | 1 | 20150825 | 20151111 | 0 | |
126814272 | 12681427 | 2 | 20151112 | 20160610 | 0 | |
126814272 | 12681427 | 4 | 20160606 | 20160612 | 0 | |
126814272 | 12681427 | 5 | 20150825 | 0 | ||
126814272 | 12681427 | 6 | 20150825 | 0 | ||
126814272 | 12681427 | 7 | 20150826 | 0 | ||
126814272 | 12681427 | 8 | 20150826 | 0 | ||
126814272 | 12681427 | 9 | 20160121 | 0 | ||
126814272 | 12681427 | 10 | 20160526 | 0 | ||
126814272 | 12681427 | 12 | 20120316 | 0 |